CVs to become ‘natural’ part of the toolkit for small- and mid-market GPs – Golding
GP-led deals will be a common staple within the small- and mid-cap markets, where there is more runway for company growth, head of secondaries Richard Wilmes told Secondaries Investor on the back of the firm's over €510m raise.
SECONDARIES INVESTOR
Register to unlock this content
Daily global secondaries market news and intelligence
Curated insights to keep you ahead of GP-led and LP-led secondaries
Faster, data-driven decision making powered by our AI interface, 'Ask PEI'
Access to proprietary research and reports
Selected fund performance and investor activity data






